Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Clinical trial NCT04683939 · TERMINATED

Trial details

NCT number: NCT04683939
Sponsor: BioNTech SE
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Gastric Cancer Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Pancreatic Cancer Biliary Tract Cancer Cholangiocarcinoma Metastatic Cancer

Start date: 2022-01-18
Primary completion: 2023-07-24
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.